ERBB2 and invasive breast carcinoma: Human epidermal growth factor receptor-2 (HER2) gene amplification occurs in approximately 20% of invasive breast cancers and portends a poorer prognosis with higher rates of recurrence and shorter progression-free survival (PFS) and overall survival (OS) [1].